Patents by Inventor Noccolo Terrando

Noccolo Terrando has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220112281
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Applicant: The Kennedy Trust for Rheumatology Research
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman, Jagdeep Nanchahal
  • Patent number: 11220540
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: January 11, 2022
    Assignee: THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman, Jagdeep Nanchahal
  • Publication number: 20200123245
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: October 23, 2019
    Publication date: April 23, 2020
    Applicant: The Kennedy Trust for Rheumatology Research
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman